CR Group L.P. - 03 May 2024 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
10%+ Owner
Signature
/s/ Nathan D. Hukill, authorized signatory for CR Group LP, CRG Partners III LP, CRG Partners III - Parallel Fund (A) LP, CRG Partners III (Cayman) Unlev AIV I LP, CRG Partners III (Cayman) Lev AIV I LP, and CRG Partners III - Parallel Fund B (Cayman) LP
Issuer symbol
TTOO
Transactions as of
03 May 2024
Net transactions value
$0
Form type
4
Filing time
07 May 2024, 16:57:09 UTC
Previous filing
16 Apr 2024
Next filing
13 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Award +648,139 +95% 1,330,175 03 May 2024 By CRG Partners III L.P. F1, F2
transaction TTOO Common Stock Award +403,608 +95% 828,324 03 May 2024 By CRG Partners III - Parallel Fund (A) L.P. F1, F2
transaction TTOO Common Stock Award +129,629 +95% 266,038 03 May 2024 By CRG Partners III (Cayman) Unlev AIV I L.P. F1, F2
transaction TTOO Common Stock Award +1,565,445 +79% 3,548,707 03 May 2024 By CRG Partners III (Cayman) Lev AIV I L.P. F1, F2
transaction TTOO Common Stock Award +2,001,514 +228% 2,879,929 03 May 2024 By CRG Partners III - Parallel Fund B (Cayman) L.P. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to that certain Securities Purchase Agreement, dated May 3, 2024, by and among the Company, CRG Partners III L.P., CRG Partners III - Parallel Fund (A) L.P., CRG Partners III (Cayman) Unlev AIV I L.P., CRG Partners III (Cayman) Lev AIV I L.P. and CRG Partners III - Parallel Fund B (Cayman) L.P. (collectively, the "CRG Entities"), the CRG Entities received these shares of common stock in exchange for the CRG Entities surrendering for cancellation of certain outstanding debt.
F2 CR Group L.P. may be deemed to beneficially own these shares by virtue of its position as the investment manager for the CRG Entities.